C. Perou, T. Sorlie, M. Eisen, M. Van-de-rijn, S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-52, 2000.
DOI : 10.1038/35021093

T. Sorlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.98, issue.19, pp.10869-74, 2001.
DOI : 10.1073/pnas.191367098

D. Slamon, G. Clark, S. Wong, W. Levin, A. Ullrich et al., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, vol.235, issue.4785, pp.177-82, 1987.
DOI : 10.1126/science.3798106

J. Ursini-siegel, B. Schade, R. Cardiff, and W. Muller, Insights from transgenic mouse models of ERBB2-induced breast cancer, Nature Reviews Cancer, vol.2, issue.5, pp.389-97, 2007.
DOI : 10.1038/nrc2127

S. Barondes, V. Castronovo, D. Cooper, R. Cummings, K. Drickamer et al., Galectins: A family of animal ??-galactoside-binding lectins, Cell, vol.76, issue.4, pp.597-605, 1994.
DOI : 10.1016/0092-8674(94)90498-7

S. Barondes, D. Cooper, M. Gitt, H. Leffler, and . Galectins, Structure and function of a large family of animal lectins, J Biol Chem, vol.269, pp.20807-20817, 1994.

I. Nabi, J. Shankar, and J. Dennis, The galectin lattice at a glance, Journal of Cell Science, vol.128, issue.13, pp.2213-2222, 2015.
DOI : 10.1242/jcs.151159

A. Fortuna-costa, A. Gomes, E. Kozlowski, M. Stelling, and M. Pavao, Extracellular Galectin-3 in Tumor Progression and Metastasis, Frontiers in Oncology, vol.945, issue.4, p.24982845, 2014.
DOI : 10.1007/978-1-62703-125-7_13
URL : http://doi.org/10.3389/fonc.2014.00138

M. Shekhar, P. Nangia-makker, L. Tait, F. Miller, and A. Raz, Alterations in Galectin-3 Expression and Distribution Correlate with Breast Cancer Progression, The American Journal of Pathology, vol.165, issue.6, pp.1931-1972, 2004.
DOI : 10.1016/S0002-9440(10)63245-2

A. Moisa, P. Fritz, A. Eck, H. Wehner, T. Murdter et al., Growth/adhesion-regulatory tissue lectin galectin-3: stromal presence but not cytoplasmic/nuclear expression in tumor cells as a negative prognostic factor in breast cancer, Anticancer Res, vol.27, pp.2131-2140, 2007.

H. Zhang, M. Luo, X. Liang, D. Wang, X. Gu et al., Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer, PLoS ONE, vol.24, issue.1, p.25254965, 2014.
DOI : 10.1371/journal.pone.0103482.t003

S. Fernandez-aguilar and J. Noel, Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast, APMIS, vol.14, issue.1, pp.33-40, 2008.
DOI : 10.1007/s10585-005-1265-8

J. Koo and W. Jung, Clinicopathlogic and Immunohistochemical Characteristics of Triple Negative Invasive Lobular Carcinoma, Yonsei Medical Journal, vol.52, issue.1, pp.89-97, 2011.
DOI : 10.3349/ymj.2011.52.1.89

A. Grosset, M. Labrie, M. Vladoiu, E. Yousef, L. Gaboury et al., Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets, Oncotarget, 2016.
DOI : 10.18632/oncotarget.7784
URL : https://hal.archives-ouvertes.fr/pasteur-01351190

M. Demers, A. Rose, A. Grosset, K. Biron-pain, L. Gaboury et al., Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells, The American Journal of Pathology, vol.176, issue.6, pp.3023-3054, 2010.
DOI : 10.2353/ajpath.2010.090876
URL : https://hal.archives-ouvertes.fr/pasteur-00819591

H. Miwa, W. Koba, E. Fine, O. Giricz, P. Kenny et al., Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer, Glycobiology, vol.23, issue.12, pp.1477-90, 2013.
DOI : 10.1093/glycob/cwt075
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816629

C. Jones, A. Mackay, A. Grigoriadis, A. Cossu, J. Reis-filho et al., Expression Profiling of Purified Normal Human Luminal and Myoepithelial Breast Cells: Identification of Novel Prognostic Markers for Breast Cancer, Cancer Research, vol.64, issue.9, pp.3037-3082, 2004.
DOI : 10.1158/0008-5472.CAN-03-2028

J. Lu, H. Pei, M. Kaeck, and H. Thompson, Gene expression changes associated with chemically induced rat mammary carcinogenesis, Molecular Carcinogenesis, vol.19, issue.2, pp.204-219, 1997.
DOI : 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M

W. Muller, E. Sinn, P. Pattengale, R. Wallace, and P. Leder, Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene, Cell, vol.54, issue.1, pp.105-120, 1988.
DOI : 10.1016/0092-8674(88)90184-5

G. Gendronneau, S. Sidhu, D. Delacour, T. Dang, C. Calonne et al., Galectin-7 in the Control of Epidermal Homeostasis after Injury, Molecular Biology of the Cell, vol.19, issue.12, pp.5541-5550, 2008.
DOI : 10.1091/mbc.E08-02-0166
URL : https://hal.archives-ouvertes.fr/hal-00326943

F. Bernerd, A. Sarasin, and T. Magnaldo, Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes, Proceedings of the National Academy of Sciences, vol.96, issue.20, pp.11329-11363, 1999.
DOI : 10.1073/pnas.96.20.11329

G. Gendronneau, S. Sanii, T. Dang, F. Deshayes, D. Delacour et al., Overexpression of galec- tin-7 in mouse epidermis leads to loss of cell junctions and defective skin repair, PLoS One, vol.10, p.25741714, 2015.

M. Moumen, A. Chiche, S. Cagnet, V. Petit, R. K. Faraldo et al., The mammary myoepithelial cell, The International Journal of Developmental Biology, vol.55, issue.7-8-9, pp.763-71, 2011.
DOI : 10.1387/ijdb.113385mm

F. Poirier and E. Robertson, Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin, Development, vol.119, pp.1229-1265, 1993.

C. Colnot, D. Fowlis, M. Ripoche, I. Bouchaert, and F. Poirier, Embryonic implantation in galectin 1/galectin 3 double mutant mice, 4<306:: AID-AJA2>3.0.CO;2-L PMID, pp.306-319, 1998.
DOI : 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L

M. Seki, S. Oomizu, K. Sakata, A. Sakata, T. Arikawa et al., Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis, Clinical Immunology, vol.127, issue.1, pp.78-88, 2008.
DOI : 10.1016/j.clim.2008.01.006

D. Oliveira, J. De-matos, A. Barros, R. Ribeiro, C. Chen et al., Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors, Anticancer Res, vol.34, pp.2211-2232, 2014.

T. Kouo, L. Huang, A. Pucsek, M. Cao, S. Solt et al., Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells, Cancer Immunology Research, vol.3, issue.4, pp.412-435, 2015.
DOI : 10.1158/2326-6066.CIR-14-0150

C. Lu, C. Speers, Y. Zhang, X. Xu, J. Hill et al., Effect of Epidermal Growth Factor Receptor Inhibitor on Development of Estrogen Receptor-Negative Mammary Tumors, JNCI Journal of the National Cancer Institute, vol.95, issue.24, pp.1825-1858, 2003.
DOI : 10.1093/jnci/djg117